|
advertisement
|
|
|
| Journal Articles Details
|
|
More January, 2004 pharmacogenomics journal articles.- PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
by Klein TE, Altman RB.
Journal: Pharmacogenomics J. 4(1):1
- Development of analytical technology in pharmacogenetic research.
by Daly AK.
Journal: Naunyn Schmiedebergs Arch Pharmacol. 09 2003;369(1):133-40
- In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.
by Garrison MW, Schimmels JA, Madaras-Kelly KJ.
Journal: Diagn Microbiol Infect Dis. 47(4):587-93
- A step past chemotherapy.
by Kalb C.
Journal: Newsweek. 142(23):73-4
- Challenges of implementing pharmacogenetics in the critical care environment.
by Freeman BD, McLeod HL.
Journal: Nat Rev Drug Discov. 3(1):88-93
- Pharmacogenetic rescue in time and space of the rutabaga memory impairment by using Gene-Switch.
by Mao Z, Roman G, Zong L, Davis RL.
Journal: Proc Natl Acad Sci U S A. 12 2003;101(1):198-203
- Pharmacogenomics, genetic tests, and patent-based incentives.
by Meurer MJ.
Journal: Adv Genet. 50:399-426; discussion 507-10
- Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
by Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ.
Journal: Toxicol Sci. 11 2003;77(1):19-34
- Pharmacogenetics of paraoxonases: a brief review.
by Draganov DI, La Du BN.
Journal: Naunyn Schmiedebergs Arch Pharmacol. 10 2003;369(1):78-88
- Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity.
by Etienne MC, Ilc K, Formento JL, Laurent-Puig P, Formento P, Cheradame S, Fischel JL, Milano G.
Journal: Br J Cancer. 90(2):526-34
- Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib.
by McLean LA, Gathmann I, Capdeville R, Polymeropoulos MH, Dressman M.
Journal: Clin Cancer Res. 10(1 Pt 1):155-65
- Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways.
by Parsons AB, Brost RL, Ding H, Li Z, Zhang C, Sheikh B, Brown GW, Kane PM, Hughes TR, Boone C.
Journal: Nat Biotechnol. 12 2003;22(1):62-9
- Atovaquone/proguanil resistance in Africa: a case report.
by David KP, Alifrangis M, Salanti A, Vestergaard LS, Rønn A, Bygbjerg IB.
Journal: Scand J Infect Dis. 35(11-12):897-8
- Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.
by Jørgensen LB, Christensen MB, Gerstoft J, Mathiesen LR, Obel N, Pedersen C, Nielsen H, Nielsen C.
Journal: Scand J Infect Dis. 35(11-12):800-7
- Pharmacogenomics and coagulation disorders.
by Iqbal O.
Journal: Methods Mol Med. 93:253-66
- Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
by Morley KI, Hall WD.
Journal: J Mol Med. 11 2003;82(1):21-30
- "Cocktail" approaches and strategies in drug development: valuable tool or flawed science?
by Zhou H, Tong Z, McLeod JF.
Journal: J Clin Pharmacol. 44(2):120-34
- [Pharmacology in epilepsy. Where are we heading for?]
by Herranz JL.
Journal: Rev Neurol. 2004 Jan 16-31;38(2):167-72
- Watson and Crick 50 years on. From double helix to pharmacogenomics.
by Sweeney BP.
Journal: Anaesthesia. 59(2):150-65
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|